What is the global market size of the Vascular Grafts Market?

Global Vascular Grafts Market size was valued at USD 3.8 billion in 2021 and is poised to grow from USD 4.08 billion in 2022 to USD 7.16 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Who are the key vendors in the Global Vascular Grafts Market?

Global vascular grafts market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Medtronic plc', 'W. L. Gore and Associates, Inc.', 'Getinge AB', 'LeMaitre Vascular, Inc.', 'Cook Medical', 'B.Braun', 'C. R. Bard', 'Terumo Corporation', 'Endologix', 'Shanghai Suokang Medical Implants Co. Ltd.', 'Cardinal Health'

What is the key driver of the Global Vascular Grafts Market?

One of the main risk factors for diabetes, hypertension, cardiovascular diseases, and other diseases is chronic kidney disease (CKD), also known as chronic kidney failure. It involves a progressive decline in kidney function. Advanced chronic kidney disease can cause the body to accumulate hazardous amounts of fluids, electrolytes, and waste. Over 37 million adults in the U.S. have CKD, according to the National Institute of Diabetes and Digestive and Kidney Diseases. The prevalence of cardiovascular disorders is increased by hereditary factors, alcohol and tobacco use, and lifestyle choices. The WHO estimates that 17.9 million deaths worldwide in 2019 were caused by cardiovascular diseases (CVDs), or 32% of all deaths. About 85% of these were caused by heart attacks and strokes. Additionally, as more people are diagnosed with cancer, there is a greater need for implantable ports & grafts and central venous catheters to administer chemotherapy drugs and blood transfusions.

What is the key market trend for the Global Vascular Grafts Market?

The adoption of the MIDCAB procedure has increased due to the rising demand for minimally invasive procedures and its safety and low mortality rate. Additionally, it is compatible with cardiopulmonary bypass and aortic cross-clamp. Additionally, it is anticipated that in the coming years, the development of surgical procedures utilizing coronary artery stent grafts will increase demand for vascular grafts.

Which region accounted for the largest share in the Global Vascular Grafts Market?

North America accounted for a major global vascular graft market share in 2021, due to increasing health consciousness and the accessibility of cardiovascular treatment facilities within the region. Furthermore, the existence of reimbursement guidelines and the use of sophisticated technological procedures are also driving market expansion.

Vascular Grafts Market Size, Share, Growth Analysis, By Product(Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease), By End User(Hospitals, Ambulatory Surgical Centers, and Others), By Application(Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, and Coronary Artery Disease), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2177 | Region: Global | Published Date: September, 2024
Pages: 242 | Tables: 120 | Figures: 68

Vascular Grafts Market News

In August 2024, Terumo India, a leading provider of medical devices and technologies announced the launch of its new abdominal stent graft system. TREO® Stent-Graft System was launched for the treatment of infrarenal abdominal aortic aneurysms in adults.
In August 2023, Aquedeon Medical Inc., a leading medical device company announced that it had received approval from the United States Food and Drug Administration (FDA) for trials of its new vascular graft systems. IDE clinical trials of Auqedeon’s Duett vascular graft system will help in reducing the time for vascular procedures.
Back in May 2021, Healionics, a biotechnology start-up announced that it had raised USD 4.7 million to promote the commercialization of its new blood vessel technology. The company offers vascular grafts called STARgraft which are highly resistant to the issue of vascular occlusion.

Vascular Grafts Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Vascular Grafts Market size was valued at around USD 1.5 billion in 2022 and is expected to rise from USD 1.6 billion in 2023 to reach a value of USD 2.8 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

Vascular graft manufacturers should focus on making their products more affordable to enhance the accessibility to vascular procedures. Addressing the risks of complications and failures will also be crucial in determining the vascular grafts industry growth potential going forward. Vascular grafts providers should also focus on gaining new approvals for advanced vascular grafts designed for minimally invasive procedures. 'Medtronic ', 'Terumo ', 'C. R. Bard ', 'B. Braun Melsungen AG ', 'Cardinal Health ', 'Endologix ', 'LeMaitre Vascular ', 'Cook Medical ', 'Maquet ', 'Gore Medical'

Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from cardiovascular diseases such as atherosclerosis, coronary artery disease, and peripheral artery disease. These indications are being treated with vascular repair procedures and surgeries thereby driving vascular grafts sales as well.

Development of Bioengineered Vascular Grafts: Bioengineered vascular grafts mimic the function of blood vessels and reduce the risk of infection and rejection that is prevalent in conventional vascular grafts. The use of bioresorbable materials and regenerative medicine approaches in vascular graft development is expected to offer a plethora of new opportunities for new as well as established vascular graft companies in the long run.

North America secures the top spot when it comes to global vascular grafts demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and rising prevalence of diseases requiring vascular treatment and surgeries are helping the high vascular grafts market share of this region. The United States is slated to emerge as the most opportune market in North America owing to surge in geriatric patient population. Canada is also estimated to boost the demand for vascular grafts in this region going forward. Availability of favorable reimbursement policies and quick adoption of advanced medical technologies are also expected to bolster market growth in North America through 2031.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Vascular Grafts Market News

Vascular Grafts Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Vascular Grafts Market?

Who are the key vendors in the Vascular Grafts Market?

What is the key driver of Vascular Grafts Market?

What is the key market trend for Vascular Grafts Market?

Which region accounted for the largest share in Vascular Grafts Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300